Femasys (FEMY) Amortization of Deferred Charges (2020 - 2026)
Femasys' (FEMY) quarterly Amortization of Deferred Charges came in at $118180.0 in Q1 2026, down 10.61% YoY from $132207.0 in Q1 2025, and down 88.19% on a QoQ basis from $1.0 million in Q4 2025.
Femasys (FEMY) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Amortization of Deferred Charges data on file, last reported at $118180.0 in Q1 2026.
- Quarterly Amortization of Deferred Charges fell 10.61% year-over-year to $118180.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 81.57% YoY) and the FY2025 annual result came in at $1.4 million, up 16.31% from the prior year.
- Amortization of Deferred Charges declined to $118180.0 in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $1.0 million in Q4 2025 to a low of $77935.0 in Q4 2022.
- A 5-year average of $286619.9 and a median of $272181.5 in 2024 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2023 — Amortization of Deferred Charges jumped 444.69% — and 2025, when it sank 48.92%.
- Tracing FEMY's Amortization of Deferred Charges over 5 years: stood at $77935.0 in 2022, then jumped by 444.69% to $424504.0 in 2023, then fell by 20.45% to $337672.0 in 2024, then jumped by 196.4% to $1.0 million in 2025, then slumped by 88.19% to $118180.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $118180.0 (Q1 2026), $1.0 million (Q4 2025), and $426541.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Femasys | 9.97 Mn | 8.53 Mn | 189,391.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118,180.00 |
| Mar 31, 2026 | 118,180.00 |
| Dec 31, 2025 | 1.00 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 426,541.00 |
| Sep 30, 2025 | 426,541.00 |
| Jun 30, 2025 | 389,913.00 |
| Jun 30, 2025 | 389,913.00 |
| Mar 31, 2025 | 132,207.00 |
| Mar 31, 2025 | 132,207.00 |
| Dec 31, 2024 | 337,672.00 |
| Dec 31, 2024 | 337,672.00 |
| Sep 30, 2024 | 310,540.00 |
| Sep 30, 2024 | 310,540.00 |
| Jun 30, 2024 | 285,561.00 |
| Jun 30, 2024 | 285,561.00 |
| Mar 31, 2024 | 258,802.00 |
| Mar 31, 2024 | 258,802.00 |
| Dec 31, 2023 | 424,504.00 |
| Dec 31, 2023 | 424,504.00 |